Associated Banc-Corp stock fell 1.64 percent on October 7

Published on 10/08/2026 at 02:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays raised its target for Associated Banc-Corp stock to USD 35.00 from USD 34.00 on October 5, 2026. Q2 EPS reached USD 0.73 against USD 0.72 consensus.

ASB, US0454871056, Illustration mit AI erstellt.

Associated Banc-Corp stock (ISIN US0454871056) fell 1.64 percent to USD 28.42 on October 7, 2026 at 3:59 p.m. EDT on the NYSE. The move came as Barclays raised its price target from USD 34.00 to USD 35.00 while maintaining an Overweight rating, according to MarketBeat on October 5, 2026.

Barclays lifts target to USD 35.00

The new Barclays target stands USD 6.58 above the October 7 share price, putting the target 23.1 percent above the price. The analyst retained the Overweight view as the bank approaches its next quarterly reporting date.

MarketBeat also reported a consensus rating of Moderate Buy, based on six Buy ratings and six Hold ratings, with an average target of USD 32.00. That average target lies 12.6 percent above the October 7 price, a narrower gap than Barclays' individual target.

Q2 earnings beat the estimate

Associated Banc-Corp reported Q2 2026 earnings of USD 0.73 per share against USD 0.72 consensus, according to MarketBeat. Revenue reached USD 454.54 million, compared with analyst estimates of USD 438.01 million, while the year-earlier EPS was USD 0.65.

The Q2 figures give the target increase a fundamental counterweight, but the next earnings release will test whether the revenue and earnings improvement continued into Q3. Simply Wall St lists October 22, 2026 as the date for the Q3 2026 results.

Market value remains substantial

Associated Banc-Corp had a market capitalization of USD 5.4 billion and trading volume of 1,737,336 shares on October 7, 2026. The 52-week range was USD 23.86 to USD 32.46, leaving the share price USD 4.04 below the yearly high.

Associated Banc-Corp stock after the decline

The October 7 price of USD 28.42 and the 1.64 percent daily decline put the stock below Barclays' USD 35.00 target while keeping it above the 52-week low of USD 23.86. The October 22 results are the next company-specific checkpoint for the valuation case.